Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

HKG:6955 Revenue

In the year 2025, Shandong Boan Biotechnology had annual revenue of 784.82M CNY with 8.06% growth. Shandong Boan Biotechnology had revenue of 391.41M in the half year ending December 31, 2025, with 9.67% growth.

• Revenue: 784.82M CNY
• Revenue Growth: +8.06%
• P/S Ratio: 3.49
• Revenue / Employee: 1.13M CNY
• Employees: 696
• Market Cap: 3.05B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	784.82M	58.51M	8.06%
Dec 31, 2024	726.32M	108.19M	17.50%
Dec 31, 2023	618.13M	102.17M	19.80%
Dec 31, 2022	515.96M	357.26M	225.11%
Dec 31, 2021	158.70M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 16, 2026

Data Sources Report a data error